Home > Boards > US Listed > Biotechs > Ekso Bionics Holdings, Inc. (EKSO)

I'm not surprised that Ekso device got this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Rhetorical Member Profile
 
Followed By 3
Posts 1,280
Boards Moderated 1
Alias Born 01/16/16
160x600 placeholder
Securities Registration Statement (s-1) Edgar (US Regulatory) - 7/2/2020 6:15:58 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/26/2020 4:25:23 PM
Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients... GlobeNewswire Inc. - 6/25/2020 8:30:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/18/2020 4:28:47 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 6/16/2020 8:01:47 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/15/2020 4:20:16 PM
Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules GlobeNewswire Inc. - 6/10/2020 1:30:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2020 5:14:38 PM
Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire Inc. - 6/8/2020 8:00:10 AM
Ekso Bionics® Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program GlobeNewswire Inc. - 6/3/2020 8:00:10 AM
Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture GlobeNewswire Inc. - 5/20/2020 4:10:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 6:04:02 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/30/2020 4:47:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2020 4:25:35 PM
Ekso Bionics Reports First Quarter 2020 Results GlobeNewswire Inc. - 4/30/2020 4:05:10 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/28/2020 6:09:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/24/2020 4:17:26 PM
Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020 GlobeNewswire Inc. - 4/23/2020 7:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2020 4:27:24 PM
Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results GlobeNewswire Inc. - 4/9/2020 4:01:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 5:04:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 5:01:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:58:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:55:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 4:23:03 PM
Rhetorical   Friday, 06/26/20 11:21:09 AM
Re: radly post# 6436
Post # of 6463 
I'm not surprised that Ekso device got this clearance while others have not.

I'd point to the fact that EksoNR senses and responds hundreds of times per second. This, combined with Ekso's integration of Functional Electronic Stimulation (FES) speak volumes to me. I think their work in these areas shows the way they approach the problem. I think they are deeply concerned with the nerve signaling and being able to work in similar frequency regimes.

If you recognize this as value through the understanding the biomechanics, I think you'll see Ekso's value. Their stock has a major discrepancy (even still I'd contend) between value and price. This price is not the fault of the company, but the lack of investors who can't possibly recognize or understand why the value exists.

Now we have bump from FDA clearance, but what is really going behind the FDA rationale and why Ekso has the better products is really the more important picture to me.

Even so, if your truly LONG - you may still well come out ahead in the future.

If this is a rocket launch, I'd say these are just the ignition sparks.

Netflix's Space Force episode 5 has the crux of the episode featured around picking the right exoskeleton. Pretty cool.

I'm long EKSO


P.S. A recent Voices From DARPA epidosde was about vagus nerve signaling via stimulation and how this might be able to treat diabetes, ptsd, rls, irritable bowel - and is already approved for depression and epilepsy. I don't mean to get off topic, just to say that our understanding in nerve signaling in relation to medicine (as Ekso is involved in) is moving very rapidly and could be an entirely new paradigm being ushered in. I don't see other exoskeleton companies as being as far ahead as Ekso in this regard.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist